Published in Support Care Cancer on September 28, 2005
Health related quality of life in a nationally representative sample of haematological patients. Eur J Haematol (2009) 1.20
Health-related quality of life during the last three months of life in patients with advanced cancer. Support Care Cancer (2008) 1.00
Determinants of quality of life in patients with advanced cancer. Support Care Cancer (2010) 0.95
Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment. Support Care Cancer (2013) 0.85
Health-related quality of life and needs of care and support of adult Tanzanians with cancer: a mixed-methods study. Health Qual Life Outcomes (2012) 0.84
Patterns of fatigue related to advanced disease and radiotherapy in patients with cancer-a comparative cross-sectional study of fatigue intensity and characteristics. Support Care Cancer (2008) 0.83
Psychological distress and quality of life of palliative cancer patients and their caring relatives during home care. Support Care Cancer (2014) 0.80
Application of adenosine 5'-triphosphate (ATP) infusions in palliative home care: design of a randomized clinical trial. BMC Public Health (2007) 0.78
Age and Gender Moderate the Impact of Early Palliative Care in Metastatic Non-Small Cell Lung Cancer. Oncologist (2015) 0.77
Kinesitherapy alleviates fatigue in terminal hospice cancer patients-an experimental, controlled study. Support Care Cancer (2009) 0.77
Age-based disparities in end-of-life decisions in Belgium: a population-based death certificate survey. BMC Public Health (2012) 0.75
Safety, efficacy, and patient-perceived satisfaction of peripherally inserted central catheters in terminally ill cancer patients: a prospective multicenter observational study. Support Care Cancer (2016) 0.75
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
Cancer pain relief and palliative care. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser (1990) 7.38
Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA (2002) 5.30
Palliative Care: the World Health Organization's global perspective. J Pain Symptom Manage (2002) 4.33
Measuring quality of life: Using quality of life measures in the clinical setting. BMJ (2001) 3.97
Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer (2001) 3.20
A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer (2000) 2.34
The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors. Palliat Med (2003) 2.18
The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer (2000) 2.12
Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer (1999) 1.98
Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating. J Pain Symptom Manage (2001) 1.91
Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer (1997) 1.85
Nutritional support of the cancer patient. CA Cancer J Clin (1998) 1.68
Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial. Palliat Med (1999) 1.64
Health-related quality of life measured by the EORTC QLQ-C30--reference values from a large sample of Swedish population. Acta Oncol (2000) 1.62
The psychosocial impact of cancer on older versus younger patients and their families. Cancer (1994) 1.61
Using reference data on quality of life--the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur J Cancer (1998) 1.60
Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3). J Clin Oncol (1998) 1.59
Diagnosis and management of delirium near the end of life. Ann Intern Med (2001) 1.57
Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer (2004) 1.56
The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer (1995) 1.56
The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group. Qual Life Res (1998) 1.43
Impact of fatigue on quality of life in oncology patients. Semin Hematol (2000) 1.39
Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer (2001) 1.30
Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1997) 1.29
Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage (1992) 1.22
Changes in quality of life following admission to palliative care units. Palliat Med (2001) 1.18
Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics. Br J Cancer (2001) 1.15
Self-assessment in cancer patients referred to palliative care: a study of feasibility and symptom epidemiology. Cancer (2002) 1.12
Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol (2004) 1.10
Correlation between physical performance and fatigue in cancer patients. Ann Oncol (1997) 1.05
Symptom recognition in advanced cancer. A comparison of nursing records against patient self-rating. Acta Anaesthesiol Scand (2001) 1.05
The influence of personal expectations on cancer patients' reports of health-related quality of life. Psychooncology (1997) 1.02
Demographic, symptom, and medication profiles of cancer patients seen by a palliative care consult team in a tertiary referral hospital. J Pain Symptom Manage (2000) 0.98
Measuring symptom distress in patients with lung cancer. A pilot study of experienced intensity and importance of symptoms. Cancer Nurs (2000) 0.96
Nutritional issues in cancer management. Nutrition (1996) 0.96
Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile. Acta Oncol (1992) 0.95
The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique. Qual Life Res (1993) 0.95
Quality of life and independence in activities of daily living preoperatively and at follow-up in patients with colorectal cancer. Support Care Cancer (1997) 0.95
Quality of life profile: from measurement to clinical application. Breast (2002) 0.94
Symptomatology of cancer patients in palliative care: content validation of self-assessment questionnaires against medical records. Eur J Cancer (2002) 0.93
Assessment of quality of life in palliative care--psychometric properties of a short questionnaire. Acta Oncol (1999) 0.92
Measurement of quality of life in women with breast cancer. Development of a Life Satisfaction Questionnaire (LSQ-32) and a comparison with the EORTC QLQ-C30. Qual Life Res (1996) 0.91
Recruiting vulnerable populations for research: revisiting the ethical issues. J Prof Nurs (2003) 0.90
Quality of life in patients with endocrine tumors of the gastrointestinal tract: patient and staff perceptions. Cancer Nurs (1998) 0.87
Quality of life of palliative care patients in the last two weeks of life. J Pain Symptom Manage (2002) 0.87
Is good 'quality of life' possible at the end of life? An explorative study of the experiences of a group of cancer patients in two different care cultures. J Clin Nurs (2001) 0.84
Quality of life and the treatment of advanced lung cancer. Clin Lung Cancer (2003) 0.83
Quality of life in patients with prostatic cancer: results from a Swedish population study. J Urol (1997) 0.81
Quality of life assessment in advanced cancer. Palliat Med (1996) 0.79
Gender differences in the dimensions of quality of life. Oncol Nurs Forum (1998) 0.78
The lived experience of constipation in cancer patients in palliative hospital-based home care. Int J Palliat Nurs (2004) 0.77
Self-reported symptom distress in cancer patients: reflections of disease, illness or sickness? Soc Sci Med (1991) 0.77
Swedish nurses' estimation of fatigue as a symptom in cancer patients--report of a questionnaire. Eur J Cancer Care (Engl) (1997) 0.77
Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J Virol (2006) 1.30
Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion. Br J Cancer (1992) 1.28
How to identify potential fallers in a stroke unit: validity indexes of 4 test methods. J Rehabil Med (2006) 1.18
Late human cytomegalovirus (HCMV) proteins inhibit differentiation of human neural precursor cells into astrocytes. J Neurosci Res (2007) 1.17
One-leg stance in healthy young and elderly adults: a measure of postural steadiness? Clin Biomech (Bristol, Avon) (2004) 1.15
Similarities and differences in assessing nausea on a verbal category scale and a visual analogue scale. Cancer Nurs (1997) 1.12
Neglect and anosognosia after first-ever stroke: incidence and relationship to disability. J Rehabil Med (2002) 1.11
Predictors of severe stroke: influence of preexisting dementia and cardiac disorders. Stroke (2002) 1.09
Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline. Br J Cancer (1994) 1.04
Increased cardiovascular disease risk in Swedish persons with paraplegia: The Stockholm spinal cord injury study. J Rehabil Med (2010) 1.02
Effects of functional electrical stimulation training for six months on body composition and spasticity in motor complete tetraplegic spinal cord-injured individuals. J Rehabil Med (2002) 1.01
Endogenous cortisol exerts antiemetic effect similar to that of exogenous corticosteroids. Br J Cancer (1993) 0.99
Cellular composition of long-term human spinal cord- and forebrain-derived neurosphere cultures. J Neurosci Res (2006) 0.96
High incidence rates of stroke in Orebro, Sweden: Further support for regional incidence differences within Scandinavia. Cerebrovasc Dis (2002) 0.94
Cardiovascular disease risk factors in persons with paraplegia: the Stockholm spinal cord injury study. J Rehabil Med (2010) 0.94
Radium treatment for hemangioma in early childhood. Reconstruction and dosimetry of treatments, 1920-1959. Acta Oncol (1990) 0.93
Induction of dopaminergic neurons from growth factor expanded neural stem/progenitor cell cultures derived from human first trimester forebrain. Brain Res Bull (2006) 0.91
Long-term culture and neuronal survival after intraspinal transplantation of human spinal cord-derived neurospheres. Physiol Behav (2007) 0.91
Cardiovascular disease risk and the need for prevention after paraplegia determined by conventional multifactorial risk models: the Stockholm spinal cord injury study. J Rehabil Med (2011) 0.91
Health care-related predictors of husbands' preparedness for the death of a wife to cancer--a population-based follow-up. Ann Oncol (2009) 0.89
Identification of novel genes regulated in the developing human ventral mesencephalon. Exp Neurol (2006) 0.88
Postural steadiness and weight distribution during tandem stance in healthy young and elderly adults. Clin Biomech (Bristol, Avon) (2005) 0.86
Cloning and expression of the human N-methyl-D-aspartate receptor subunit NR3A. Neurosci Lett (2002) 0.85
Social support and immune status during and after chemotherapy for breast cancer. Acta Oncol (1996) 0.83
The alpha7 nicotinic receptors in human fetal brain and spinal cord. J Neurochem (2002) 0.83
Higher expression of alpha7 nicotinic acetylcholine receptors in human fetal compared to adult brain. Brain Res Dev Brain Res (2003) 0.83
Prognosis for patients with neglect and anosognosia with special reference to cognitive impairment. J Rehabil Med (2003) 0.82
Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease. Dement Geriatr Cogn Disord (2012) 0.82
Late mortality during the first year after acute traumatic spinal cord injury: a prospective, population-based study. J Spinal Cord Med (2010) 0.81
Single high-dose dexamethasone improves the effect of ondansetron on acute chemotherapy-induced nausea and vomiting but impairs the control of delayed symptoms. Support Care Cancer (1996) 0.81
Fatigue dimensions in patients with advanced cancer in relation to time of survival and quality of life. Palliat Med (2008) 0.80
Anticipatory immune changes in women treated with chemotherapy for ovarian cancer. Int J Behav Med (1995) 0.80
Immune effects of relaxation during chemotherapy for ovarian cancer. Psychother Psychosom (1997) 0.80
Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor. Brain Res Bull (2005) 0.79
Palliative day care--a study of well-being and health-related quality of life. Palliat Med (2009) 0.79
Constitutive and inflammatory induction of alpha and beta chemokines in human first trimester forebrain astrocytes and neurons. Mol Immunol (2002) 0.79
Aspects of patient care. Interviews with relapse-free testicular cancer patients in Stockholm. Cancer Nurs (1992) 0.79
Movement-provoked muscle torque and EMG activity in longstanding motor complete spinal cord injured individuals. J Rehabil Med (2002) 0.79
Radiation therapy of hemangiomas, 1909-1959. A cohort based on 50 years of clinical practice at Radiumhemmet, Stockholm. Acta Oncol (1987) 0.78
Expression patterns of neurotrophic factor mRNAs in developing human teeth. Cell Tissue Res (2002) 0.78
Thyroid nodularity after diagnostic administration of iodine-131. Radiat Res (1996) 0.77
Presenilin expression during induced differentiation of the human neuroblastoma SH-SY5Y cell line. Neurochem Int (2004) 0.77
Human neural precursor cells continue to proliferate and exhibit low cell death after transplantation to the injured rat spinal cord. Brain Res (2009) 0.77
Hip fractures in persons with stroke. Stroke Res Treat (2013) 0.77
Dimensions of fatigue during radiotherapy--an application of the Swedish Occupational Fatigue Inventory (SOFI) on cancer patients. Acta Oncol (2001) 0.77
Conditioned nausea after cancer chemotherapy and autonomic nervous system conditionability. Scand J Psychol (1993) 0.77
Impact of tumour burden on chemotherapy-induced nausea and vomiting. Br J Cancer (1996) 0.76
Trait anxiety and anticipatory immune reactions in women receiving adjuvant chemotherapy for breast cancer. Brain Behav Immun (1993) 0.76
The existential impact of starting corticosteroid treatment as symptom control in advanced metastatic cancer. Palliat Med (2009) 0.76
Effects of ondansetron on chemotherapy-induced acute and delayed emesis--a pilot study. Acta Oncol (1991) 0.75
African trypanosomes activate human fetal brain cells to proliferation and IFN-gamma production. Neuroreport (2002) 0.75
Aspects of delayed chemotherapy-induced nausea. Dexamethasone and adrenal response patterns in patients and healthy volunteers. Support Care Cancer (2000) 0.75
Drug infusors in palliative medicine: a Swedish inquiry. J Pain Symptom Manage (1998) 0.75
[Advanced home care is as efficient and as expensive as hospital care according to the SBU]. Lakartidningen (2000) 0.75
[A survey of drug administration via infusion pumps. Morphine is the most frequently used drug administered by infusion pump]. Lakartidningen (1995) 0.75
Societal services after traumatic spinal cord injury in Sweden. J Rehabil Med (2003) 0.75